In an experimental setting quite similar to the present one, we have previously shown that stimulation of dMVECs with CYC-treated SSc sera preserved their ability to synthesize fibrillin-1 and the expression of the adhesion molecule αvβ3 integrin, which instead were both impaired on challenge with naïve SSc sera [33]. The gene discussed is FBN1; the disease is systemic sclerosis.